In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.22, denoting a +1.67% change from the preceding trading day.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – ...

Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.

Pacific Biosciences' Q4'24 results were another disappointment ... Growth in clinical and diagnostic markets will help, but not right away, and PACB is likely to remain below $100M in annualized ...

3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever PACB stock opened at $1.56 on Tuesday. Pacific Biosciences of California has a 12-month low of $1.16 ...

Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener ... Read More on PACB: Pacific Biosciences of California NewsMORE Related Stocks Indices ...

In the last three months, 4 analysts have published ratings on Pacific Biosciences PACB, offering a diverse ... (typically once per quarter for each stock). Analysts usually derive their ...